Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2003
09/16/2003US6620784 Uses of VEGF-E
09/16/2003US6620783 Human SMN-like protein (HSLP) and polynucleotides which identify and encode HSLP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating
09/16/2003US6620597 Ligation during amplification (LDA) of polymerase chain reaction mixtures by denaturing, annealing and cyclization; genetic replication
09/16/2003US6620593 Drug screening using oxidoreductase enzymes, then analyzing the metabolites for toxicity, mutagenicity or carcinogenicity
09/16/2003US6620591 System for cell-based screening
09/16/2003US6620589 NMR-solve method for rapid identification of Bi-ligand drug candidates
09/16/2003US6620587 Ribosome complexes as selection particles for in vitro display and evolution of proteins
09/16/2003US6620586 Analyzing nucleic acids in samples; obtain nucleotide sequences, pool, incubate with primers, hybridize, determine concentration of preferential nucleotide sequences
09/16/2003US6620585 Use of ectoenzymes and secreted enzymes to monitor cellular proliferation
09/16/2003US6620584 Combinatorial decoding of random nucleic acid arrays
09/16/2003US6620107 Detection of conditions by analysis of gases or vapours
09/16/2003US6618934 Method of manufacturing small volume in vitro analyte sensor
09/16/2003CA2250174C Test media and quantitative method for identification and differentiation of biological materials in a test sample
09/16/2003CA2226176C Hydrogel patch
09/16/2003CA2131719C Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor
09/16/2003CA2087724C Reduction of non-specific amplification during in vitro nucleic acid amplification using modified nucleic acid bases
09/12/2003WO2003075017A1 Method for analyzing a molecule comprising a support for molecules and a receiving chamber
09/12/2003WO2003075015A2 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
09/12/2003WO2003075007A2 Methods for absolute cell counting
09/12/2003WO2003075005A1 Fungal antigens and eosinophil activity
09/12/2003WO2003074999A1 Biosensor
09/12/2003WO2003074992A2 Phosphorylated proteins and uses related thereto
09/12/2003WO2003074740A1 Rapid analysis of variations in a genome
09/12/2003WO2003074739A2 Automated allele determination using fluorometric genotyping
09/12/2003WO2003074738A1 Oligonucleotide-tagged semiconductor nanocrystals for microarray and fluorescence in situ hybridization
09/12/2003WO2003074737A1 New method
09/12/2003WO2003074736A1 Diagnostics and remedies for malignant brain tumor
09/12/2003WO2003074735A1 Diagnostic method for glaucoma
09/12/2003WO2003074734A2 Methods for detecting genome-wide sequence variations associated with a phenotype
09/12/2003WO2003074733A2 Improvements in and relating to marking
09/12/2003WO2003074732A2 Methods based on hormone dependency of primary cancer cells
09/12/2003WO2003074731A2 Nucleic acid probes, their synthesis and use
09/12/2003WO2003074730A1 Method and device for determination of tissue specificity of free floating dna in bodily fluids
09/12/2003WO2003074729A1 Method for diagnosing and treating predisposition for accelerated autosomal dominant polycystic kidney disease
09/12/2003WO2003074728A2 Screening for modulators of pkng activity
09/12/2003WO2003074727A1 Rapid identification of yeasts
09/12/2003WO2003074724A2 Polynomial amplification of nucleic acids
09/12/2003WO2003074723A2 Methods for detection of genetic disorders
09/12/2003WO2003074722A2 Microarrays of cellulose binding chimeric proteins and methods of use thereof
09/12/2003WO2003074698A1 Method of determining base sequence of nucleic acid
09/12/2003WO2003074696A1 Method of detecting base substitution
09/12/2003WO2003074694A1 Adipocyte differentiation-associated genes and proteins
09/12/2003WO2003074674A2 MSRAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
09/12/2003WO2003074671A2 Mbcats as modifiers of the beta-catenin pathway and methods of use
09/12/2003WO2003074664A2 Cloning and characterization of slc26a7 and slc26a9 anion exchangers
09/12/2003WO2003074662A2 SCDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
09/12/2003WO2003074658A2 Multivariate random search method with multiple starts and early stop for identification of differentially expressed genes based on microarray data
09/12/2003WO2003074657A2 Cold shock inducible expression and production of heterologous polypeptides
09/12/2003WO2003074571A2 Cationic polyelectrolytes in biomolecule purification and analysis
09/12/2003WO2003074558A2 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
09/12/2003WO2003074548A2 Phage ligand sensor devices and uses thereof
09/12/2003WO2003074073A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003WO2003074069A2 Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1)
09/12/2003WO2003073991A2 Methods to increase or decrease bone density
09/12/2003WO2003073990A2 Treatment for asthma or allergies
09/12/2003WO2003073987A2 Compounds that modulate the activity of ptp-1b and tc-ptp
09/12/2003WO2003073983A2 Methods and compositions in treating pain using diacylglycerol kinase epsilon
09/12/2003WO2003073980A2 Recombinant protein c variants
09/12/2003WO2003073823A2 PDPK1s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
09/12/2003WO2003073821A2 Shc PROTEIN-RELATED METHODS AND COMPOSITIONS FOR THE PROGNOSIS OF BREAST, PROSTATE AND OVARIAN CANCER
09/12/2003WO2003073817A2 Rapid and sensitive detection of cells and viruses
09/12/2003WO2003056033A8 Non- or minimally invasive monitoring methods
09/12/2003WO2003053535A3 Nanoparticle imaging system and method
09/12/2003WO2003052375A3 Device and methods for monitoring the status of at least one cell
09/12/2003WO2003052074A8 Nucleic acid diagnostic reagents and methods for detecting nucleic acids, polynucleotides and oligonucleotides
09/12/2003WO2003050269A3 HIGH RESOLUTION TYPING SYSTEM FOR PATHOGENIC $i(E. COLI)
09/12/2003WO2003046505A3 Device for detecting carbon dioxide and method for determining a microbiological contamination of a fluid
09/12/2003WO2003046133A3 Regulatory nucleic acid assay for diagnostic and library screens
09/12/2003WO2003033735A3 Test strip assay system and method for the detection of specific nucleic acid sequences
09/12/2003WO2003032814A3 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof
09/12/2003WO2003031579A3 Human tyrosine-dna phosphodiesterase variant polypeptides and methods of use therefor
09/12/2003WO2003031063A3 Device for holding a substance library carrier
09/12/2003WO2003025212A3 Method for detecting sepsis
09/12/2003WO2003018834A3 Displacement assay for the detection of nucleic acid oligomer hybridization events
09/12/2003WO2003018833A3 3-hydroxymethylglutaryl coenzyme a reductase and diagnosis and prognostication of dementia
09/12/2003WO2003018757A3 Stabilization of cells and biological specimens for analysis
09/12/2003WO2003007794A3 Invasion complex and methods of targeting
09/12/2003WO2003006612A3 Production of transduced hematopoietic progenitor cells
09/12/2003WO2003001877A3 Methods for the diagnosis and treatment of cardiac tissue rejection
09/12/2003WO2003001201A3 Method for the extra-corporeal qualitative and/or quantitative recording of neuro-toxic substances in the blood plasma of an individual
09/12/2003WO2002097132A3 Nucleic acid detection method
09/12/2003WO2002097128A3 Method for identifying substances directed against myocardial cell hypertrophy
09/12/2003WO2002094976A3 Identification of antimicrobial agents
09/12/2003WO2002090581A3 A molecular tag code for monitoring a product and process using same
09/12/2003WO2002090569A3 Family-based association tests for quantitative traits using pooled dna
09/12/2003WO2002088314A3 Ovary-specific genes and proteins
09/12/2003WO2002083077A3 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
09/12/2003WO2002082041A3 Production and use of novel peptide-based agents for use with bi-specific antibodies
09/12/2003WO2002079513A3 Method for the detection and quantification of the fungus stachybotrys chartarum using quantitative pcr
09/12/2003WO2002075507A3 Anti-bacterial vaccine compositions
09/12/2003WO2002072830A3 Proteins associated with cell growth, differentiation, and death
09/12/2003WO2002072772A3 Methods and compositions for amplification of rna sequences
09/12/2003WO2002070736A3 Method for the detection of nucleic acid molecules
09/12/2003WO2002068682A3 Method for identifying biologically active structures of microbial pathogens
09/12/2003WO2002062205A3 Methods for diagnosing and treating heart disease
09/12/2003WO2002057414A9 Leukocyte expression profiling
09/12/2003WO2002048401A3 Nested oligonucleotides containing hairpin for nucleic acid amplification
09/12/2003WO2002048370A3 Compositions and methods relating to colon specific genes and proteins
09/12/2003WO2002046468A3 Method for maldi-tof-ms analysis and/or sequencing of oligonucleotides
09/12/2003WO2002046464A3 Ligand detection method
1 ... 2049 2050 2051 2052 2053 2054 2055 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 ... 3003